Nature's Sunshine Products, Inc. is a natural health and wellness company engaged in the manufacturing and direct selling of nutritional and personal care products. Founded in 1976, the company operates through four geographic segments: Asia, Europe, North America, and Latin America and Other. Its product portfolio includes over 800 items categorized into general health, immune support, cardiovascular health, digestive health, personal care, and weight management. The company sources raw materials such as herbs and botanicals, which are formulated, encapsulated, or concentrated into finished goods. Manufacturing is primarily conducted at a facility in Spanish Fork, Utah, with some production outsourced to contract manufacturers. Distribution is managed through a network of independent consultants who resell products to consumers, supported by regional warehouses in the United States and international distribution centers. The company operates under the Nature’s Sunshine and Synergy WorldWide brands, holding trademark registrations in the United States and numerous other countries. It maintains quality control procedures to verify product purity and potency, and its operations are subject to seasonal variations based on regional holidays and cultural events.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Household & Personal Products Homepage naturessunshine.com
Sector Consumer Defensive IR page ir.naturessunshine.com
Tags
dietary supplements, herbal products, direct selling, personal care, immune support, digestive health, cardiovascular health, weight management, botanicals, nutritional products, Nature’s Sunshine, Synergy WorldWide, Probiotic Eleven, Brain Edge, Lymphatic Drainage, Chlorophyll Stick Packs, Liquid Chlorophyll Extra Strength, Lower Bowel Stimulator, Vegitabs, Magnesium Complex, Silver Shield, Calming Stress, Detox & Cleansing, Hair Skin & Nails, Fitness & Energy, Heart Health, Sleep Support, Brain & Memory, Anxiousless, Power of Beets, HSN-W, Turmeric Curcumin, Food Enzymes
Press page ir.naturessunshine.com/news-events/press-releases

Metrics

Valuation  
Market cap $ 169.487M
Market cap (USD) $ 169.487M
P/E 11.89
PEG —
P/BV 0.99
P/S 0.35
P/OCF 8.63
P/FCF 16.13
Dividend yield 10.3%
Turnover / mcap —
Returns  
ROE 12.1%
ROI 23.4%
ROIC 20.4%
Profit margin 4.1%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y No
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock Yes
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 7
Quality score 61.1%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Revenue 480.144M 454.364M 445.32M 421.91M 444.084M 385.205M 362.215M 364.81M 342.029M 341.159M 324.705M 366.367M 378.096M 367.468M 367.813M 349.918M 343.023M 381.299M 366.647M 362.222M — 331.063M 258.208M 298.734M 318.722M 314.82M
Net profit 19.521M 7.696M 15.076M 550K 30.207M 22.958M 6.929M -1.202M -13.817M 675K 13.656M 9.8M 17.609M 25.38M 17.601M -1.233M 6.115M -1.838M -8.237M -3.565M 3.504M 17.078M 5.099M 7.064M 16.659M 17.131M
Free cash flow 28.841M 14.327M 30.748M -6.918M 27.942M 32.754M 3.441M 16.999M 5.023M -7.611M -12.365M -12.103M 20.808M 20.022M 1.489M 13.555M -2.284M -6.732M 8.376M 11.534M 12.728M 9.955M 13.592M 6.255M 10.301M 24.141M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Share price 21.58 14.66 17.29 8.32 18.5 14.95 8.93 8.15 11.55 15 10.12 14.82 17.32 16.26 16.17 8.49 7.6 5.64 — 8.5 — — — — — —
Price performance 12m 0.47 -0.15 1.08 -0.55 0.24 0.67 0.1 -0.29 -0.23 0.48 -0.32 -0.14 0.07 0.01 0.9 0.12 0.35 — — — — — — — — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 7.74M 8.89M 7.75M 7.32M 7.38M 8.87M 14.1M 8.83M 9.48M 8.6M
↳ YoY growth +0.5% +14.9% -12.8% -5.6% +0.8% +20.3% +59.0% -37.4% +7.4% -9.2%
↳ 5y CAGR -4.7% -1.6% -5.4% +1.7% -0.9% +2.8% +9.7% +2.6% +5.3% +3.1%
Borrowings, current (USD) 9.92M 0.00 — 0.00 1.31M 1.24M 1.17M 0.00 — —
Borrowings, non-current (USD) — — — 0.00 2.42M 1.17M 0.00 — — —
Lease liabilities (USD) — — 24M 25.2M 21.4M 20.3M 18M 14.9M 14.2M 18.9M
Cash and deposits (USD) 32.3M 42.9M 50.6M 53.6M 92.1M 86.2M 60M 82.4M 84.7M 93.9M
Intangible assets (USD) 976,000 709,000 618,000 567,000 — — — — — —
Right-of-use assets (USD) — — 23.1M 24M 20.2M 18.3M 16.1M 13.4M 12.8M 17.6M
Net debt (borrowings + leases - cash) (USD) -22.4M -42.9M — -28.5M -66.9M -63.5M -40.8M -67.5M — —
Cash flow detail
Operating cash flow (USD) 3.42M 10.5M 21.8M 8.55M 37.7M 34.6M 710,000 41.2M 25.3M 35.3M
Purchases of property, plant and equipment (USD) -11M -5.5M -4.83M -5.1M -4.91M -6.67M -7.63M -10.5M -11M -6.48M
Purchases of intangible assets (USD) -509,000 0.00 0.00 — — — — — — —
Change in receivables (cash effect) (USD) -343,000 -1.24M 189,000 375,000 106,000 -1.68M -5.94M 4.92M -1.12M 1.02M
Change in inventories (cash effect) (USD) -9.57M 5.18M 1.07M -4.87M -154,000 -14.5M -8.84M 995,000 5.56M -7.82M
Change in payables (cash effect) (USD) -935,000 -1.12M 1.04M -960,000 2.09M 3.08M -2.8M 1.42M 1.09M -1.8M
Dividends paid (cash effect) (USD) -7.51M -1.85M 0.00 — 0.00 -19.9M 0.00 — — —
Share buybacks (cash effect) (USD) 0.00 0.00 — — 0.00 -7.43M -13.6M -6.4M -8.86M -16.3M
Interest paid (cash effect) (USD) -254,000 -257,000 -397,000 -64,000 -86,000 -202,000 -264,000 -539,000 -119,000 -98,000
Income taxes paid (cash effect) (USD) -3.59M -4.6M -3.54M -6.86M -4.83M -6.22M -5.61M -9.26M -14.8M -12.5M
Share-based compensation (USD) 3.22M 2.22M 2.17M 2.12M 3.79M 3.73M 2.9M 4.89M 4.79M 5.78M
Operating cash flow before change in receivables (USD) 3.76M 11.8M 21.6M 8.17M 37.6M 36.3M 6.65M 36.3M 26.4M 34.3M
Free cash flow (OCF - PPE - intangibles) (USD) -8.12M 5.02M 17M 3.44M 32.8M 27.9M -6.92M 30.7M 14.3M 28.8M
Income detail
Research and development expense (USD) 3.2M 3.4M 2.8M 2.1M 1.5M 1.4M 1.5M 1.6M 1.7M 1.9M
↳ 5y CAGR +15.6% +18.4% +6.5% -3.1% -11.7% -15.2% -15.1% -10.6% -4.1% +4.8%
Total comprehensive income (USD) 658,000 -12.7M -2.18M 6.81M 24.2M 30M -2.56M 14.4M 6.57M 19.6M
Comprehensive income to owners (USD) 658,000 -12.7M -2.18M 6.81M 24.2M 30M -3.5M 13M 6.37M 18.6M
Provision for credit losses (USD) 305,000 215,000 818,000 10,000 77,000 -47,000 45,000 45,000 0.00 —
Credit cost ratio (credit losses / average receivables) (%) 4.0% 2.6% 9.8% 0.1% 1.0% 0.6% 0.4% 0.4% 0.0% —
Reported Mar 14, 2017 Mar 16, 2018 Nov 7, 2019 Mar 10, 2021 Mar 8, 2022 Mar 8, 2022 Mar 16, 2023 Mar 12, 2024 Mar 11, 2025 Mar 10, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Nature's Sunshine Reports Third Quarter 2026 Results Bull 0 Bear 5 Results

Download as PDF November 04, 2026 4:05pm EST

Related Documents

Audio

Earnings Webcast

Presentation

PDF

10-Q Filing

PDF HTML

XBRL

ZIP HTML

LEHI, Utah, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (Nasdaq: NATR) ("Nature’s Sunshine"), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, reported financial results for the third quarter ended September 30, 2026.

Third Quarter 2026 Financial Summary vs. Same Year-Ago Quarter

  • Net sales were down 9% to $116.6 million compared to $128.3 million (down 7% in constant currency).
  • Gross profit margin decreased 42 basis points to 72.9% compared to 73.3%.
  • GAAP net income attributable to common shareholders was $1.9 million, or $0.11 per diluted common share, compared to $5.3 million, or $0.30 per diluted common share.
  • Adjusted EBITDA was $11.1 million compared to $15.2 million.

Management Commentary

"Our third-quarter results were disappointing and fell short of our expectations,” said Ken Romanzi, CEO of Nature’s Sunshine. “We faced several challenges in our business, particularly in China and in our Digital business. In China, operational disruptions have had a more significant impact on our consultant leadership base than we initially anticipated which we have already begun rebuilding. Further, following several quarters of exceptional growth in our Digital business, we are continuing to invest in this critical part of our portfolio to position it for the next phase of growth."

"While our third quarter performance was far from our expectations, our confidence in the long-term potential of Nature's Sunshine remains strong."

Third Quarter 2026 Financial Results

Net Sales by Operating Segment (Amounts in Thousands)
Three Months Ended September 30, 2026 2025 Percent Change Impact of Currency Exchange Percent Change Excluding Impact of Currency
Asia $ 55,056 $ 64,725 (14.9)% $ (2,437 ) (11.2)%
Europe 22,076 22,107 (0.1 ) (227 ) 0.9
North America 34,009 36,224 (6.1 ) (42 ) (6.0 )
Latin America and Other 5,462 5,283 3.4 182 (0.1 )
$ 116,603 $ 128,339 (9.1)% $ (2,524 ) (7.2)%

Net sales in the third quarter of 2026 decreased 9% to $116.6 million compared to $128.3 million in the same year-ago quarter. Excluding the impact from foreign exchange rates, net sales in the third quarter of 2026 decreased 7% compared to the year-ago quarter.

Gross profit margin in the third quarter of 2026 decreased to 72.9% compared to 73.3% in the year-ago quarter. The decrease is primarily due to unfavorable foreign exchange.

Volume incentives as a percentage of net sales were 32.0% compared to 30.7% in the year-ago quarter. The increase was primarily due to timing of promotional incentives and market mix.

Selling, general and administrative expenses ("SG&A") in the third quarter of 2026 were $42.3 million compared to $45.7 million in the year‐ago quarter. The decrease was primarily related to a reduction in variable selling expenses and cost management. As a percentage of net sales, SG&A expenses were 36.3% for the third quarter of 2026 compared to 35.6% in the year-ago quarter.

Operating income in the third quarter of 2026 decreased to $5.3 million, or 4.5% of net sales, compared to $9.0 million, or 7.0% of net sales, in the year-ago quarter.

Other income (expense), net, in the third quarter of 2026 was $0.1 million compared to $0.7 million in the year-ago quarter. The provision for income taxes was $3.5 million in the third quarter of 2026 compared to $4.1 million for the year-ago quarter.

GAAP net income attributable to common shareholders decreased to $1.9 million, or $0.11 per diluted common share, compared to $5.3 million, or $0.30 per diluted common share, in the year-ago quarter. As a result of the December 2025 purchase of noncontrolling interests, there was no net income attributable to NSP China for the third quarter of 2026, compared to $1.0 million, or $0.06 per diluted common share, in the year-ago quarter.

Adjusted EBITDA in the third quarter of 2026 decreased to $11.1 million compared to $15.2 million in the year-ago quarter. Adjusted EBITDA, which is a non-GAAP financial measure, is defined here as net income from continuing operations before taxes, depreciation, amortization, and other income (expense) adjusted to exclude share-based compensation expense and certain noted adjustments. A reconciliation of net income to adjusted EBITDA is provided in the attached financial tables.

Balance Sheet and Cash Flow

Net cash provided by operating activities was $9.7 million for the nine months ended September 30, 2026, compared to $25.4 million in the prior year period. Capital expenditures during the nine months ended September 30, 2026, totaled $6.8 million compared to $4.1 million in the comparable period of 2025. During the nine months ended September 30, 2026, the Company repurchased 345,000 shares at a total cost of $6.1 million or $17.66 per share. As of September 30, 2026, the Company had cash and cash equivalents of $89.4 million and zero debt.

Outlook

Reflecting the impact of a stronger U.S. dollar and recent challenges in the China market, Nature's Sunshine now expects full year 2026 net sales to range between $460 and $470 million ($490 and $500 million prior). Adjusted EBITDA is now expected to range between $44 and $48 million ($48 and $52 million prior).

Conference Call

The Company will hold a conference call today at 5:00 p.m. Eastern time to discuss its third quarter of 2026 results.

Date: Wednesday, November 4, 2026
Time: 5:00 p.m. Eastern time (3:00 p.m. Mountain time)
Toll-free dial-in number: 1-800-717-1738
International dial-in number: 1-646-307-1865
Conference ID: 30563

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Gateway Group at 1-949-574-3860.

The conference call will be broadcast live and available for replay here and via the Events section of the Nature’s Sunshine website here .

A replay of the conference call will be available after 8:00 p.m. Eastern time on the same day through Wednesday, November 18, 2026.

Toll-free replay number: 1-844-512-2921
International replay number: 1-412-317-6671
Replay ID: 1130563

About Nature’s Sunshine Products

Nature’s Sunshine Products (Nasdaq: NATR), a leading natural health and wellness company, markets and distributes nutritional and personal care products in more than 40 countries. Nature’s Sunshine manufactures most of its products through its own state-of-the-art facilities to ensure its products continue to set the standard for the highest quality, safety, and efficacy on the market today. Additional information about the company can be obtained at its website, www.naturessunshine.com.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements regarding the Company’s future business expectations, which are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans, strategies and financial results, including expected improvements in gross profit and gross margin. All statements (other than statements of historical fact) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. These statements are often characterized by terminology such as “believe,” “hope,” “may,” “anticipate,” “should,” “intend,” “plan,” “will,” “expect,” “estimate,” “project,” “positioned,” “strategy” and similar expressions, and are based on assumptions and assessments made in light of our experience and perception of historical trends, current conditions, expected future developments and other factors we believe to be appropriate. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, including the following:

  • failure to comply with laws and regulations relating to trade restrictions and export controls;
  • laws and regulations regarding direct selling that may prohibit or restrict our ability to sell our products in some markets or require us to make changes to our business model in some markets;
  • corrective or remedial actions involving independent sales representatives that may disrupt their sales organizations or adversely affect our sales and results of operations;
  • current and potential future extensive government regulations to which the Company’s products, business practices and manufacturing activities are subject;
  • registration of products for sale in foreign markets, or difficulty or increased cost of importing products into foreign markets;
  • legal challenges to the Company’s direct selling program or to the classification of its independent consultants;
  • failure of the Company’s independent consultants to comply with advertising laws;
  • product liability claims;
  • impact of anti-bribery laws, including the U.S. Foreign Corrupt Practices Act;
  • the Company’s ability to attract and retain independent consultants;
  • the loss of one or more key independent consultants who have a significant sales network;
  • potential for liability relating to the Company’s full ownership of its China business;
  • the effect of fluctuating foreign exchange rates;
  • liabilities and obligations arising from improper activity by the Company’s independent consultants;
  • changes to the Company’s independent consultant compensation plans;
  • geopolitical issues, conflicts or other global events;
  • negative consequences resulting from difficult economic conditions, including the availability of liquidity or the willingness of the Company’s consumers to purchase products;
  • risks associated with the manufacturing of the Company’s products;
  • supply chain disruptions, manufacturing interruptions or delays or the failure to accurately forecast consumer demand;
  • failure to timely and effectively obtain shipments of products from our suppliers and deliver products to our independent consultants and consumers;
  • uncertainties relating to the application of transfer pricing, duties, value-added taxes and other tax regulations, and changes thereto;
  • failure to maintain an effective system of internal controls over financial reporting;
  • cybersecurity threats and exposure to data loss;
  • the storage, processing and use of data, some of which contain personal information, are subject to complex and evolving privacy and data protection laws and regulations;
  • reliance on information technology infrastructure; and
  • the sufficiency of trademarks and other intellectual property rights.

These and other risks and uncertainties that could cause actual results to differ from predicted results are more fully detailed under the caption “Risk Factors” in our reports filed with the Securities and Exchange Commission, including our Annual Report on Form 10-K and Quarterly Reports filed on Form 10-Q.

All forward-looking statements speak only as of the date of this press release and are expressly qualified in their entirety by the cautionary statements included in or incorporated by reference into this press release. Except as is required by law, the Company expressly disclaims any obligation to publicly release any revisions to forward-looking statements to reflect events after the date of this press release.

Non-GAAP Financial Measures

We have included information which has not been prepared in accordance with generally accepted accounting principles (GAAP), such as information concerning non-GAAP net income, adjusted EBITDA and net sales excluding the impact of foreign currency exchange fluctuations.

We believe that these non-GAAP measures provide investors with greater transparency to evaluate operational activities and financial results and facilitate consistent comparisons to the historical operating performance of prior periods. We utilize these non-GAAP measures of non-GAAP net income and adjusted EBITDA in the evaluation of our operations and believe that these measures are useful indicators of our operating performance and ability to fund our business. These non-GAAP financial measures should not be considered as an alternative to, or more meaningful than, U.S. GAAP net income (loss) as an indicator of our operating performance.

Other companies may use the same or similarly named measures, but exclude different items, which may not provide investors with a comparable view of Nature’s Sunshine Products’ performance in relation to other companies. We have included a reconciliation of net income, the most comparable GAAP measure, to adjusted EBITDA. We have also included a reconciliation of GAAP net income to non-GAAP net income and non-GAAP adjusted EPS, in the attached financial tables.

Net sales in local currency removes, from net sales in U.S. dollars, the impact of changes in exchange rates between the U.S. dollar and the functional currencies of our foreign subsidiaries. This is accomplished by translating the current period's net sales into U.S. dollars using the same foreign currency exchange rates that were used to translate the net sales for the previous comparable period.

We believe presenting the impact of foreign currency fluctuations is useful to investors because it allows a more meaningful comparison of net sales of our foreign operations from period to period. Net sales excluding the impact of foreign currency fluctuations should not be considered in isolation or as an alternative to net sales in U.S. dollar measures that reflect current period exchange rates, or to other financial measures calculated and presented in accordance with U.S. GAAP.

With respect to our adjusted EBITDA outlook for the full year 2026, a quantitative reconciliation to the corresponding GAAP information cannot be provided without unreasonable effort because of the inherent difficulty of accurately forecasting the occurrence and financial impact of the various adjusting items necessary for such reconciliation that have not yet occurred, are out of our control, or cannot be reasonably predicted, including stock based compensation and other potential adjustments. For the same reasons, we are unable to assess the probable significance of the unavailable information, which could have a material impact on our future GAAP financial results.

Investor Relations:

Gateway Group, Inc.
Cody Slach
1-949-574-3860
[email protected]

NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Amounts in thousands, except per share information)(Unaudited)
Three Months Ended September 30, Nine Months Ended September 30,
2026 2025 2026 2025
Net sales $ 116,603 $ 128,339 $ 356,480 $ 356,337
Cost of sales 31,641 34,290 95,367 98,392
Gross profit 84,962 94,049 261,113 257,945
Operating expenses:
Volume incentives 37,365 39,348 110,075 108,552
Selling, general and administrative 42,315 45,726 130,730 129,972
Operating income 5,282 8,975 20,308 19,421
Other income (expense):
Interest and other income, net 101 51 336 524
Interest expense (30 ) (26 ) (118 ) (71 )
Foreign exchange gains (losses), net 15 672 (1,637 ) 4,451
86 697 (1,419 ) 4,904
Income before provision for income taxes 5,368 9,672 18,889 24,325
Provision for income taxes 3,478 4,137 8,343 8,387
Net income 1,890 5,535 10,546 15,938
Net income attributable to noncontrolling interests — 201 — 524
Net income attributable to common shareholders $ 1,890 $ 5,334 $ 10,546 $ 15,414
Basic and diluted net income per common share:
Basic earnings per share attributable to common shareholders $ 0.11 $ 0.30 $ 0.60 $ 0.85
Diluted earnings per share attributable to common shareholders $ 0.11 $ 0.30 $ 0.59 $ 0.83
Weighted average basic common shares outstanding 17,519 17,638 17,553 18,174
Weighted average diluted common shares outstanding 17,870 18,034 17,906 18,563
NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (Amounts in thousands) (Unaudited)
September 30, 2026 December 31, 2025
Assets
Current assets:
Cash and cash equivalents $ 89,377 $ 93,891
Accounts receivable, net of allowance for doubtful accounts of $60 and $69, respectively 18,325 8,602
Inventories 71,289 68,312
Prepaid expenses and other 9,394 8,040
Total current assets 188,385 178,845
Property, plant and equipment, net 29,701 32,915
Operating lease right-of-use assets 19,023 17,600
Restricted investment securities - trading 1,225 1,132
Deferred income tax assets 19,328 20,068
Other assets 10,570 10,586
Total assets $ 268,232 $ 261,146
Liabilities and Shareholders’ Equity
Current liabilities:
Accounts payable $ 8,151 $ 8,021
Accrued volume incentives and service fees 25,758 22,624
Accrued liabilities 27,523 34,080
Deferred revenue 5,910 5,840
Income taxes payable 1,577 4,703
Current portion of operating lease liabilities 4,569 3,270
Total current liabilities 73,488 78,538
Liability related to unrecognized tax benefits 1,748 428
Long-term portion of operating lease liabilities 16,459 15,630
Deferred compensation payable 1,225 1,132
Deferred income tax liabilities 1,069 954
Other liabilities 2,561 2,911
Total liabilities 96,550 99,593
Shareholders’ equity:
Common stock, no par value, 50,000 shares authorized, 17,386 and 17,508 shares issued and outstanding, respectively 99,179 102,192
Retained earnings 87,474 76,928
Accumulated other comprehensive loss (14,971 ) (17,567 )
Total shareholders’ equity 171,682 161,553
Total liabilities and shareholders’ equity $ 268,232 $ 261,146
NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Amounts in thousands) (Unaudited)
Nine Months Ended September 30, 2026 2025
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income $ 10,546 $ 15,938
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 9,735 10,538
Non-cash lease expense 3,123 3,792
Share-based compensation expense 5,585 4,223
Deferred income taxes 1,012 (2,104 )
Purchase of trading investment securities (220 ) (94 )
Proceeds from sale of trading investment securities 287 14
Realized and unrealized gains on investments (161 ) (112 )
Foreign exchange (gains) losses 1,637 (4,451 )
Changes in assets and liabilities:
Accounts receivable (9,507 ) (5,254 )
Inventories (2,900 ) (6,428 )
Prepaid expenses and other current assets (1,334 ) (1,323 )
Other assets 398 (465 )
Accounts payable 525 (2,401 )
Accrued volume incentives and service fees 2,751 4,165
Accrued liabilities (7,219 ) 5,412
Deferred revenue (226 ) 4,615
Lease liabilities (2,421 ) (3,883 )
Income taxes payable (3,286 ) 2,814
Liability related to unrecognized tax benefits 1,320 235
Deferred compensation payable 94 192
Net cash provided by operating activities 9,739 25,423
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant and equipment (6,793 ) (4,143 )
Net cash used in investing activities (6,793 ) (4,143 )
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from revolving credit facility 30,935 1,823
Principal payments of revolving credit facility (30,935 ) (1,823 )
Payments related to tax withholding for net-share settled equity awards (2,502 ) (872 )
Repurchase of common stock (6,096 ) (14,376 )
Net cash used in financing activities (8,598 ) (15,248 )
Effect of exchange rates on cash and cash equivalents 1,138 4,822
Net increase (decrease) in cash and cash equivalents (4,514 ) 10,854
Cash and cash equivalents at the beginning of the period 93,891 84,700
Cash and cash equivalents at the end of the period $ 89,377 $ 95,554
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for income taxes, net of refunds $ 9,457 $ 7,699
Cash paid for interest 118 71
NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA (Amounts in thousands) (Unaudited)
Three Months Ended September 30, Nine Months Ended September 30,
2026 2025 2026 2025
Net income $ 1,890 $ 5,535 $ 10,546 $ 15,938
Adjustments:
Depreciation and amortization 3,211 3,539 9,735 10,538
Share-based compensation expense 1,955 1,285 5,585 4,223
Other (income) expense, net* (86 ) (697 ) 1,419 (4,904 )
Provision for income taxes 3,478 4,137 8,343 8,387
Other adjustments (1) 689 1,386 1,419 3,239
Adjusted EBITDA $ 11,137 $ 15,185 $ 37,047 $ 37,421
(1) Other adjustments
Other non-recurring expenses $ 689 $ 1,386 $ 1,419 $ 3,239
Total adjustments $ 689 $ 1,386 $ 1,419 $ 3,239

* Other (income) expense, net is primarily comprised of foreign exchange (gains) losses, interest income, and interest expense.

NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES RECONCILIATION OF GAAP NET INCOME TO NON-GAAP NET INCOME and NON-GAAP ADJUSTED EPS (Amounts in thousands) (Unaudited)
Three Months Ended September 30, Nine Months Ended September 30,
2026 2025 2026 2025
Net income $ 1,890 $ 5,535 $ 10,546 $ 15,938
Adjustments:
Other non-recurring expenses 689 1,386 1,419 3,239
Tax impact of adjustments (172 ) (347 ) (355 ) (810 )
Total adjustments 517 1,039 1,064 2,429
Non-GAAP net income $ 2,407 $ 6,574 $ 11,610 $ 18,367
Reported income attributable to common shareholders $ 1,890 $ 5,334 $ 10,546 $ 15,414
Total adjustments 517 1,039 1,064 2,429
Non-GAAP net income attributable to common shareholders $ 2,407 $ 6,373 $ 11,610 $ 17,843
Basic income per share, as reported $ 0.11 $ 0.30 $ 0.60 $ 0.85
Total adjustments, net of tax 0.03 0.06 0.06 0.13
Basic income per share, as adjusted $ 0.14 $ 0.36 $ 0.66 $ 0.98
Diluted income per share, as reported $ 0.11 $ 0.30 $ 0.59 $ 0.83
Total adjustments, net of tax 0.03 0.06 0.06 0.13
Diluted income per share, as adjusted $ 0.14 $ 0.36 $ 0.65 $ 0.96

Primary Logo

Source: Nature's Sunshine Products, Inc.

Released November 4, 2026

Nature’s Sunshine Products, Inc.

© NATURE'S SUNSHINE 2026

Facebook Twitter Pinterest Youtube Instagram

©2026 Nature's Sunshine Products, Inc. All rights reserved.

Product information only applies to the U.S.

PRIVACY POLICY WEBSITE TERMS OF USE RETURN POLICY

Better Business Bureau Healthiest Companies 2018 Most Trustworthy 2013 USDA Organic ISO

Q3 2026 Financial Results Conference Call Bull 0 Bear 0 Routine

Nov 4, 2026 5:00 pm EST

A replay of the conference call is available after 8:00 p.m. Eastern time on the same day through Wednesday, November 18, 2026.

Toll-free replay number: 1-844-512-2921
International replay number: 1-412-317-6671
Replay ID: 1130563

Earnings Release

PDF HTML

Audio

Earnings Webcast

Presentation

PDF

10-Q Filing

PDF HTML

XBRL

ZIP HTML

Nature’s Sunshine Products, Inc.

© NATURE'S SUNSHINE 2026

Facebook Twitter Pinterest Youtube Instagram

©2026 Nature's Sunshine Products, Inc. All rights reserved.

Product information only applies to the U.S.

PRIVACY POLICY WEBSITE TERMS OF USE RETURN POLICY

Better Business Bureau Healthiest Companies 2018 Most Trustworthy 2013 USDA Organic ISO

October 21, 2026 4:05pm EDT

LEHI, Utah, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (Nasdaq: NATR) ("Nature’s Sunshine" and/or the "Company"), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, will conduct a conference call on Wednesday, November 4, 2026, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the third quarter ended September 30, 2026. The Company will report its financial results in a press release prior to the conference call.

Nature’s Sunshine management will host the conference call, followed by a question-and-answer period.

Date: Wednesday, November 4, 2026

Time: 5:00 p.m. Eastern time (3:00 p.m. Mountain time)

Toll-free dial-in number: 1-800-717-1738

International dial-in number: 1-646-307-1865

Conference ID: 30563

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Gateway Group at 1-949-574-3860.

The conference call will be broadcast live and available for replay here

and via the Events section of the Nature’s Sunshine website here

.

A replay of the conference call will be available after 8:00 p.m. Eastern time on the same day through Wednesday, November 18, 2026.

Toll-free replay number: 1-844-512-2921

International replay number: 1-412-317-6671

Replay ID: 1130563

Prompts

Nature's Sunshine Products, Inc. (ticker NATR), listed in United States.

ETFs Holding Nature's Sunshine Products, Inc.

ETF Weight in ETF Shares Market value As of
FSML 0.32% 18,585 $ 405.153K Jun 30, 2026
SQLV 0.30% 3,917 $ 85.391K Jun 30, 2026
SYZ 0.12% 3,656 $ 79.701K Jun 30, 2026
FSEG 0.09% 238 $ 5,188.40 Jun 30, 2026
FSEV 0.07% 200 $ 4,360.00 Jun 30, 2026
FEAC 0.05% 552 $ 12.034K Jun 30, 2026
AVUV 0.03% 768,791 $ 8.118M Nov 16, 2026
VFMF 0.02% 16,272 $ 230.249K Aug 31, 2026
AVSC 0.01% 25,559 $ 269.903K Nov 16, 2026
DFAT 0.01% 282,247 $ 2.901M Nov 12, 2026
DFSV 0.01% 226,719 $ 2.331M Nov 12, 2026
DFAS 0.00% 121,508 $ 1.249M Nov 12, 2026
DXUV 0.00% 14,736 $ 151.486K Nov 12, 2026
DFSU 0.00% 1,930 $ 19.84K Nov 12, 2026
MSSM 0.00% 404 $ 5,716.60 Aug 31, 2026
DCOR 0.00% 34,208 $ 351.658K Nov 12, 2026
DFAC 0.00% 58,010 $ 596.343K Nov 12, 2026
DFAU 0.00% 3,780 $ 38.858K Nov 12, 2026
DFUS 0.00% 2,512 $ 25.823K Nov 12, 2026
EBI 0.00% 47 $ 665.05 Aug 31, 2026
DFUV 0.00% 1,029 $ 10.578K Nov 12, 2026
AVUS 0.00% 9,603 $ 101.408K Nov 16, 2026
AVSU 0.00% 252 $ 2,661.12 Nov 16, 2026
BSVO 0.00% 10,405 $ 110K Nov 18, 2026